Synopsys, Inc. vs Vanguard Total International Stock Index Fund ETF — how do they compare? Synopsys, Inc. trades at $510.35 (market cap $95.39B), while Vanguard Total International Stock Index Fund ETF trades at $84.56 (market cap $665.70B). The key difference: Vanguard Total International Stock Index Fund ETF is far larger — about 7× Synopsys, Inc.'s market cap, and Vanguard Total International Stock Index Fund ETF is more actively traded (4,864,744 versus 3,374,903). Which is the better fit depends on your goals — on Pluang, investors hold Synopsys, Inc. for 71 Days and Vanguard Total International Stock Index Fund ETF for 55 Days on average.
| SNPS | VXUS | |
|---|---|---|
Market Cap | $95.39B | $665.70B |
Volume | 3,374,903 | 4,864,744 |
Sector | Technology | Sector/Thematic |
52-Week High | $534.56 | $88.41 |
52-Week Low | $367.70 | $72.17 |
Typical Hold Time | 71 Days | 55 Days |
Enterprise Value | $102.62B | — |
Signals from Pluang's Aura AI — not financial advice
Synopsys (SNPS) trades at $502.67, down 0.49% on the day, amid a bullish technical trend and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent news highlights AI-driven partnerships with OpenAI and Amazon, boosting growth prospects. Valuation ratios are elevated, with a P/E of 86.87, reflecting high growth expectations. Analyst sentiment is overwhelmingly positive, with a consensus price target of $572.54.
The outlook for SNPS is favorable, driven by AI integration and strategic acquisitions, but risks include high valuation sensitivity and competitive pressures. Revenue growth and margin expansion from new deals present opportunities, though investors should monitor execution risks and market volatility. The stock's proximity to key resistance levels suggests potential for near-term consolidation or breakout.
VXUS, the Vanguard Total International Stock ETF, trades at $84.56, down 0.26% with a bearish technical signal. The ETF provides diversified exposure to international developed and emerging markets outside the US. Recent news highlights its role in portfolio diversification and institutional buying interest, though technical indicators show selling pressure across moving averages and oscillators.
The outlook for VXUS hinges on international market performance relative to US equities, with potential for long-term growth diversification. Risks include currency fluctuations and regional economic volatility. Institutional accumulation suggests confidence in international equity exposure as a strategic portfolio component.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →